EMEA Morning Briefing : Hamas Attack on Israel -2-
Bristol Myers Squibb will acquire Mirati Therapeutics in a transaction that values the oncology developer at up to $5.8 billion, the latest example of a drugmaker targeting deals to replenish... -October 09, 2023 at 12:15 am EDT - MarketScreener